Viewing data from:

STREPTOMYCIN SULFATE

ANDA

STREPTOMYCIN SULFATE | A060684 | JOHN D COPANOS AND CO INC

1 strength0 unique patents0 unique exclusivities

Medicare Part B Spending

CMS physician-administered drug spending for Streptomycin Sulfate (2023)

Total Spending

$360.52

Total Claims

Beneficiaries

ASP Price

—

HCPCS: J3000 — Injection, streptomycin, up to 1 gm

Source: CMS Medicare Part B Spending by Drug (2023). Shows physician-administered drug costs.

API Supply Chain1 active DMF4 inactive

1 active API supplier hold Drug Master Files for this ingredient. Limited supplier base — potential supply chain risk.

SICHUAN LONG MARCH PHARMACEUTICAL CO LTDSTREPTOMYCIN SULFATE

DMF 136431998

VETERANS ADMINISTRATIONInactiveSTREPTOMYCIN

DMF 161947

PFIZER INCInactiveSTREPTOMYCIN SULFATE

DMF 133761998

GLAXOInactiveSTREPTOMYCIN SULFATE

DMF 134011998

RHONE POULENC RORER PHARMACEUTICALS INCInactiveSTREPTOMYCIN SULFATE

DMF 134851998

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — EQ 500MG BASE/ML

0 patents0 exclusivities▴

INJECTABLE;INJECTION | Approved: Approved Prior to Jan 1, 1982

No patent or exclusivity listings for this strength.